title: Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Depil
authors.forename: Claire
authors.initials: C
authors.lastname: Mathiot
authors.forename: Xavier
authors.initials: X
authors.lastname: Leleu
authors.forename: Anne Sophie
authors.initials: AS
authors.lastname: Moreau
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Faucompré
authors.forename: Bernadette
authors.initials: B
authors.lastname: Hennache
authors.forename: Francis
authors.initials: F
authors.lastname: Bauters
authors.forename: Régis
authors.initials: R
authors.lastname: Bataille
authors.forename: Thierry
authors.initials: T
authors.lastname: Facon
mesh_terms: D015415:Biomarkers / Q000097:blood; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D009101:Multiple Myeloma / Q000097:blood / Q000175:diagnosis* / Q000401:mortality; D053244:Osteoprotegerin; D011379:Prognosis; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood*; D015996:Survival Rate
chemical_list: D015415:Biomarkers; D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human